A Clinical evaluation of Siddha formulation Gandhaga rasayanam(Internal medicine) and Arugan thylam(External medicine) for Kaanakadi(Urticaria)
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- Effect of Gandhaga rasayanam(internal) and arugan thylam(external) in the management of urticaria will be assessed by based on urticaria activity score(UAS) and IgE in study subjects before and after the treatment.
研究概览
简要总结
The aim to evaluate the effective of Gandhaga Rasayanam(internal) and Arugan thylam(external) in the management of kaanaakadi (urticaria).To assess the therapeutic efficacy of Siddha formulation Gandhaga Rasayanam and Arugan thylam in the management of kaanaakadi. This trial drug will be issued to the patient .The patient will be asked to visit OPD of Ayothidoss pandithar hospital National institute of Siddha with 40 patients once 10 days for clinical assessment. Patient selected based on inclusion and exclusion criteria. Laboratory investigation taken before and after treatment. All the data entered into computer and analysed. All collected data will be statistically analysed by Research officer (statistics) for logical errors and incompleteness of data to avoid any bias.Then final report will be generated.The outcome will be assessed by based on Urticaria Activity Score and IgE before and after treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 15.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients with clinical symptoms of Itching Redness Pale pink oedematous wheal Wheals surrounded by flare Inflamation Erythematous macules (any 2 symptoms especially itchy,wheal) Recurrent episodes of urticaria.
排除标准
- •Any serious systemic illness Psoriasis Eczema Tinea infection Pregnancy Lactation Psychological factor Adverse reaction of any drug.
结局指标
主要结局
Effect of Gandhaga rasayanam(internal) and arugan thylam(external) in the management of urticaria will be assessed by based on urticaria activity score(UAS) and IgE in study subjects before and after the treatment.
时间窗: 48 Days
次要结局
未报告次要终点